Loading...
Loading...
India's potassium imports from CHINA total $11.7B across 197 shipments from 15 foreign suppliers. SHANDONG NEW TIME PHARMACEUTICAL CO LTD leads with $10.6B in import value; the top 5 suppliers together control 99.9% of this origin. Leading Indian buyers include AUROBINDO PHARMA LTD. This corridor reflects India's pharmaceutical import demand for potassium — a diversified sourcing base with multiple active suppliers from CHINA.

SHANDONG NEW TIME PHARMACEUTICAL CO LTD is the leading Potassium supplier from CHINA to India, with import value of $10.6B across 61 shipments. The top 5 suppliers — SHANDONG NEW TIME PHARMACEUTICAL CO LTD, SINOPHARM WEIQIDA PHARMACEUTICAL, LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED, SHANDONG NEW TIME PHARMACEUTICAL, M/S. SHANDONG NEW TIME PHARMACEUTIC — collectively account for 99.9% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SHANDONG NEW TIME PHARMACEUTICAL CO LTD | $10.6B | 61 | 90.7% |
| 2 | SINOPHARM WEIQIDA PHARMACEUTICAL | $495.3M | 2 | 4.2% |
| 3 | LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED | $393.6M | 16 | 3.4% |
| 4 | SHANDONG NEW TIME PHARMACEUTICAL | $183.9M | 14 | 1.6% |
| 5 | M/S. SHANDONG NEW TIME PHARMACEUTIC | $6.4M | 28 | 0.1% |
| 6 | ZHUHAI UNITED LABORATORIES TRADING COMPANY LTD | $2.4M | 17 | 0.0% |
| 7 | SINOPHARM WEIQIDA PHARMACEUTICAL CO LTD | $1.9M | 8 | 0.0% |
| 8 | ZHUHAI UNITED LABORATORIES TRADING CO,LTD | $1.3M | 4 | 0.0% |
| 9 | SHANDONG NEW TIME PHARMACEUTICAL CO LIMITED | $1.2M | 4 | 0.0% |
| 10 | M/S. SINOPHARM WEIQIDA PHARMACEUTI | $1.0M | 5 | 0.0% |
| 11 | M/S. LONGCHEM INTERNATIONAL TRADING | $990.6K | 9 | 0.0% |
| 12 | CREDIT PHARMA CO., LIMITED | $912.4K | 5 | 0.0% |
| 13 | CREDIT PHARMA CO LIMITED | $569.6K | 1 | 0.0% |
| 14 | XXANDXXG NXX TIXX PHXXMACXXTICXX COXXLIMITED | $539.6K | 1 | 0.0% |
| 15 | SINOPHARM WEIQIDA PHARMACEUTICAL CO .,LTD | $430.7K | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD | $11.1B | 106 | 95.0% |
| 2 | GIYAAN PHARMA PRIVATE LIMITED | $394.6M | 25 | 3.4% |
| 3 | AUROBINDO PHARMA LIMITED | $185.4M | 20 | 1.6% |
| 4 | AQUATIC REMEDIES LIMITED | $2.5M | 13 | 0.0% |
| 5 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $2.2M | 7 | 0.0% |
| 6 | INJECT CARE PARENTERALS PRIVATE LIMITED | $1.3M | 11 | 0.0% |
| 7 | ARSHIYA LOGISTICS SERVICES LIMITED | $539.6K | 1 | 0.0% |
| 8 | ALKEM LABORATORIES LIMITED | $407.0K | 1 | 0.0% |
| 9 | ARSHIYA PANVEL LOGISTICS SERVICES PRIVATE LIMITED | $273.2K | 1 | 0.0% |
| 10 | JODAS EXPOIM PRIVATE LIMITED | $148.8K | 4 | 0.0% |
| 11 | AKUMS DRUGS AND PHARMACEUTICALS LIMITED | $135.3K | 1 | 0.0% |
| 12 | UNI MEDICOLABS | $60.2K | 1 | 0.0% |
| 13 | ALCHEMY MEDICINE PRIVATE LIMITED | $48.3K | 1 | 0.0% |
| 14 | AXIS CLINICALS LIMITED | $954 | 2 | 0.0% |
| 15 | WATSON PHARMA PRIVATE LIMITED | $830 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Potassium suppliers from CHINA to India include SHANDONG NEW TIME PHARMACEUTICAL CO LTD, SINOPHARM WEIQIDA PHARMACEUTICAL, LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED. The leading supplier is SHANDONG NEW TIME PHARMACEUTICAL CO LTD with import value of $10.6B USD across 61 shipments. India imported Potassium worth $11.7B USD from CHINA in total across 197 shipments.
India imported Potassium worth $11.7B USD from CHINA across 197 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Potassium sourced from CHINA include AUROBINDO PHARMA LTD, GIYAAN PHARMA PRIVATE LIMITED, AUROBINDO PHARMA LIMITED. The largest buyer is AUROBINDO PHARMA LTD with $11.1B in imports across 106 shipments.
The total value of Potassium imports from CHINA to India is $11.7B USD, across 197 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
197 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists